| Literature DB >> 36101797 |
Guangyuan Xia1, Yongxue Hu1,2, Fangxian Chai1, Yiming Wang1, Xingde Liu3.
Abstract
Objective: This paper aimed to probe changes in the default mode network (DMN) functional connectivity (DMNFC) of the brain of patients with insomnia disorder (ID) under the resting state.Entities:
Mesh:
Year: 2022 PMID: 36101797 PMCID: PMC9440808 DOI: 10.1155/2022/9197858
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.009
Figure 1Functional connectivity analysis based on the region of interest.
Figure 2Functional connectivity analysis based on the region of interest.
Figure 3Functional connectivity analysis based on the region of interest.
Figure 4Functional connectivity analysis based on the region of interest.
Intensified encephalic regions between the ID group and the healthy control group.
| Encephalic regions |
| Voxel (mm3) | Peak | ||
|---|---|---|---|---|---|
|
|
|
| |||
| Between the left medial superior frontal gyrus and the left anterior central gyrus | −30 | −15 | +51 | 383 | 5.36 |
| Between the left medial superior frontal gyrus and the anterior cingulate gyrus | −06 | +24 | +36 | 219 | 5.08 |
| Between the right medial superior frontal gyrus and the left anterior central gyrus | −48 | −06 | +48 | 229 | 4.66 |
| Between the left precuneus and the left central/posterior gyrus | −54 | −18 | +54 | 701 | 4.79 |
| Between the left precuneus and the left supraoccipital gyrus | −21 | −69 | +30 | 208 | 4.33 |
| Between the right precuneus and the left posterior central gyrus | −60 | −21 | +48 | 492 | 5.17 |
Weakening encephalic regions of the ID and healthy control groups.
| Encephalic regions |
| Voxel (mm3) | Peak t value | ||
|---|---|---|---|---|---|
|
|
|
| |||
| Between the left precuneus and the right angular gyrus | +54 | −51 | +45 | 131 | −3.64 |
| Between the left precuneus and the right middle frontal gyrus | +42 | +33 | +42 | 143 | −4.15 |
| Between the precuneus and the left inferior temporal gyrus | −51 | −12 | −42 | 171 | −4.18 |
MNI: Montreal Neurological Institute.
Comparisons of the ID and the control groups ( ± S).
| Items | Healthy control group | ID group |
|
|---|---|---|---|
| Number of cases | 65 | 67 | — |
| Age (years) | 32.8 ± 11.5 | 33.7 ± 10.2 | 0.583 |
| Gender | 38F/27M | 44 F/23M | 0.087 |
| Years of education | 16.6 ± 2.8 | 15.2 ± 3.3 | 0.437 |
| Marriage | 36Y/29N | 40Y/27N | 0.694 |
| Attendance of exercise | 42Y/23N | 38Y/29N | 0.187 |
| Age of morbidity | — | 29.4 ± 10.7 | — |
| Frequency of morbidity | — | 1.5 ± 0.7 | — |
| Duration of disease (month) | — | 38.5 ± 50.1 | — |
F: female; M: male; Y: yes; N: no.
Scores of sleep-related scale between the ID and the control groups ( ± S).
| Healthy control group | ID group |
|
| |
|---|---|---|---|---|
|
| ||||
| Sleep quality | 0.06 ± 0.25 | 2.52 ± 0.634 | 19.99 | ≤0.001 |
| Sleep latency | 0.19 ± 0.40 | 2.59 ± 0.825 | 14.44 | ≤0.001 |
| Sleep duration | 0.35 ± 0.48 | 2.52 ± 0.74 | 13.49 | ≤0.001 |
| Sleep efficiency | 1.78 ± 1.43 | 3.00 ± 0.12 | 4.61 | ≤0.001 |
| Sleep disturbances | 0.35 ± 0.49 | 1.52±-0.63 | 8.00 | ≤0.001 |
| Sleep medication | 0.06 ± 0.25 | 1.17 ± 1.13 | 5.29 | ≤0.001 |
| Daytime dysfunction | 0.26 ± 0.45 | 1.24 ± 0.87 | 5.55 | ≤0.001 |
| Global score | 6.7 ± 1.8 | 15.9 ± 2.3 | 17.82 | ≤0.001 |
| ISI | 3.6 ± 2.2 | 18.5 ± 4.0 | 23.35 | ≤0.001 |
|
| 1.9 ± 1.8 | 1.7 ± 1.8 | 0.17 | 0.893 |
| HAMD-17 | 8.5 ± 4.8 | 11.5 ± 3.3 | 2.69 | 0.670 |
: In comparison of the control group with the ID group, P < 0.05 indicates that the difference between the two groups were statistically significant.